Prof. Li Fang (李芳) — Cervical Cancer & Precancerous Lesion Diagnosis and Surgery | Oriental Hospital Shanghai
For international patients seeking comprehensive cervical disease care — from the earliest precancerous changes through to invasive cervical cancer requiring surgery — Prof. Li Fang (李芳) at Oriental Hospital Shanghai (Tongji University) offers a breadth of clinical expertise that spans the full spectrum of cervical disease management. As Director of Gynecology at one of Shanghai's major academic medical centers and a nationally recognized leader in cervical disease prevention and treatment, Prof. Li brings together diagnostic precision, surgical skill, and a comprehensive understanding of the cervical disease continuum that enables her to provide individualized care at every stage.
Her contributions to the field have been recognized with the Shanghai Medical Science and Technology Progress Award — one of the most prestigious recognitions in Shanghai's medical community — reflecting the impact of her clinical and research work on cervical disease management in China.
Specialty Focus
- Cervical precancerous lesions (CIN I–III): colposcopic diagnosis, LEEP, conization
- Cervical cancer: surgical staging, radical hysterectomy, lymphadenectomy
- Minimally invasive gynecologic surgery: laparoscopic and robotic approaches
- Open surgery for complex cervical cancer cases
- Cervical disease prevention: HPV management, screening protocols
- Ovarian and endometrial cancer: surgical management
Academic & Clinical Titles
- Chief Physician & Professor, Director of Gynecology, Oriental Hospital Shanghai (Tongji University)
- National leader in cervical disease prevention and treatment
- Winner, Shanghai Medical Science and Technology Progress Award
The Cervical Disease Continuum: From Prevention to Surgery
Cervical disease exists on a continuum — from HPV infection and precancerous lesions (CIN) at one end, through microinvasive cancer, to frankly invasive cervical cancer at the other. Optimal management requires expertise across this entire continuum, because the decisions made at each stage affect outcomes at subsequent stages: how a CIN lesion is managed affects the risk of recurrence and the options available if cancer develops; how early-stage cancer is staged and treated affects the options available if recurrence occurs.
Prof. Li Fang's clinical expertise spans this full continuum:
Cervical precancerous lesions: Expert colposcopic examination and targeted biopsy for accurate histological diagnosis. LEEP (loop electrosurgical excision procedure) for CIN II and III — the standard treatment that removes the transformation zone while preserving as much normal cervical tissue as possible. Cold knife conization for cases requiring larger excision or endocervical assessment. Management of recurrent CIN after prior treatment.
Early cervical cancer (Stages IA–IB2): Surgical staging and radical hysterectomy with pelvic lymphadenectomy. Minimally invasive approaches (laparoscopic or robotic) for selected cases. Sentinel lymph node mapping to reduce lymphadenectomy morbidity. Fertility-sparing options (radical trachelectomy) for selected young patients.
Locally advanced cervical cancer (Stages IB3–IVA): Evaluation for concurrent chemoradiation with brachytherapy, with or without immunotherapy (pembrolizumab for eligible patients). Assessment of surgical options after chemoradiation response in selected cases.
Recurrent cervical cancer: Evaluation for salvage surgery, re-irradiation, or systemic therapy. Pelvic exenteration for selected patients with central pelvic recurrence.
Minimally Invasive Surgery: Laparoscopic and Robotic Approaches
Prof. Li Fang's expertise in minimally invasive gynecologic surgery — including both laparoscopic and robotic approaches — enables her to offer patients the benefits of smaller incisions, reduced blood loss, shorter hospital stay, and faster recovery for appropriate cases. Her proficiency with both minimally invasive and open surgical techniques means that she can select the approach best suited to each patient's tumor characteristics, anatomy, and clinical situation — rather than being limited to a single surgical modality.
For patients who have been told that minimally invasive surgery is not possible for their case, Prof. Li's assessment may identify minimally invasive options that were not previously considered. For patients who require open surgery due to tumor size, vascular involvement, or prior abdominal surgery, her open surgical expertise ensures that the most technically demanding operations can be performed safely.
National Leadership in Cervical Disease Prevention
Prof. Li's recognition as a national leader in cervical disease prevention reflects her contributions beyond individual patient care — to the broader effort to reduce the burden of cervical cancer in China through improved screening, earlier detection, and more effective treatment of precancerous lesions. Her Shanghai Medical Science and Technology Progress Award recognizes the impact of this work on clinical practice and patient outcomes.
For international patients, this national leadership role means that Prof. Li's clinical approach reflects the most current evidence-based standards for cervical disease management — and that her awareness of the full landscape of cervical disease prevention and treatment enables her to provide comprehensive guidance that extends beyond the immediate clinical question.
Oriental Hospital: Comprehensive Academic Medical Center
Oriental Hospital Shanghai — affiliated with Tongji University — is one of Shanghai's major academic medical centers, with comprehensive capabilities across multiple specialties. The hospital's Department of Gynecology, which Prof. Li directs, provides the full range of gynecologic oncology services, supported by pathology, radiology, medical oncology, and radiation oncology. For international patients, the hospital's academic medical center infrastructure ensures access to the multidisciplinary resources needed for comprehensive cervical cancer care.
Who Should Consider Consulting Prof. Li Fang
- Women with cervical precancerous lesions (CIN) seeking expert diagnosis and treatment planning
- Patients with early-stage cervical cancer seeking surgical evaluation, including minimally invasive options
- Patients with locally advanced cervical cancer seeking comprehensive treatment planning
- Patients with recurrent cervical cancer seeking salvage treatment options
- Women with persistent HPV infection or recurrent CIN after prior treatment
- Patients seeking a second opinion on cervical cancer diagnosis or treatment from a nationally recognized expert
- Patients with ovarian or endometrial cancer seeking gynecologic oncology surgical evaluation
How CMCS Connects You with Prof. Li Fang
China Medical Concierge Shanghai (CMCS) facilitates access to Prof. Li Fang for international patients with cervical precancerous lesions, cervical cancer, and other gynecologic conditions. Our team manages the full coordination process — from remote case review and medical record translation to appointment scheduling, interpretation, and in-hospital support.
To begin, patients or their families are encouraged to share available medical records including HPV typing results, cervical cytology reports, colposcopy and biopsy histology reports, MRI pelvis, CT chest/abdomen/pelvis if cancer is suspected or confirmed, tumor markers, and prior treatment summaries. Prof. Li's team can conduct an initial remote assessment before any travel to Shanghai is required.
CMCS provides end-to-end support including:
- Medical record translation (English, Arabic, French, and other languages)
- Remote pre-consultation case review
- Appointment coordination with Prof. Li Fang at Oriental Hospital Shanghai
- On-site interpretation during consultations and procedures
- Post-consultation summary and follow-up support
Contact CMCS to Connect with Prof. Li Fang
📧 contract@medicalsh.com
💬 WhatsApp: https://wa.me/message/3AM6KAGCW2BAD1
🌐 www.medicalsh.com
CMCS – China Medical Concierge Shanghai connects international patients with Shanghai's leading specialists. We are a health management company, not a hospital. All clinical decisions are made by the treating physician.
0 commenti